Annual Operating Expenses
$3.94 M
+$3.09 M+361.54%
31 December 2023
Summary:
Telomir Pharmaceuticals Common Stock annual total operating expenses is currently $3.94 million, with the most recent change of +$3.09 million (+361.54%) on 31 December 2023. During the last 3 years, it has risen by +$3.80 million (+2754.45%). TELO annual operating expenses is now at all-time high.TELO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$6.01 M
+$4.53 M+307.34%
30 September 2024
Summary:
Telomir Pharmaceuticals Common Stock quarterly total operating expenses is currently $6.01 million, with the most recent change of +$4.53 million (+307.34%) on 30 September 2024. Over the past year, it has increased by +$4.93 million (+456.85%). TELO quarterly operating expenses is now at all-time high.TELO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TELO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +456.9% |
| 3 y3 years | +2754.4% | - |
| 5 y5 years | - | - |
TELO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2754.4% | at high | +8468.0% |
| 5 y | 5 years | at high | +2754.4% | at high | +8468.0% |
| alltime | all time | at high | +2754.4% | at high | +8468.0% |
Telomir Pharmaceuticals Common Stock Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.01 M(+307.3%) |
| June 2024 | - | $1.47 M(-23.0%) |
| Mar 2024 | - | $1.92 M(+77.6%) |
| Dec 2023 | $3.94 M | $1.08 M(+13.0%) |
| Sept 2023 | - | $954.20 K(-33.1%) |
| June 2023 | - | $1.43 M(+195.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $482.90 K(-0.9%) |
| Dec 2022 | $854.10 K(+518.5%) | - |
| Dec 2022 | - | $487.10 K(+108.6%) |
| Sept 2022 | - | $233.50 K(+233.1%) |
| June 2022 | - | $70.10 K |
| Dec 2021 | $138.10 K | - |
FAQ
- What is Telomir Pharmaceuticals Common Stock annual total operating expenses?
- What is the all time high annual operating expenses for Telomir Pharmaceuticals Common Stock?
- What is Telomir Pharmaceuticals Common Stock quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Telomir Pharmaceuticals Common Stock?
- What is Telomir Pharmaceuticals Common Stock quarterly operating expenses year-on-year change?
What is Telomir Pharmaceuticals Common Stock annual total operating expenses?
The current annual operating expenses of TELO is $3.94 M
What is the all time high annual operating expenses for Telomir Pharmaceuticals Common Stock?
Telomir Pharmaceuticals Common Stock all-time high annual total operating expenses is $3.94 M
What is Telomir Pharmaceuticals Common Stock quarterly total operating expenses?
The current quarterly operating expenses of TELO is $6.01 M
What is the all time high quarterly operating expenses for Telomir Pharmaceuticals Common Stock?
Telomir Pharmaceuticals Common Stock all-time high quarterly total operating expenses is $6.01 M
What is Telomir Pharmaceuticals Common Stock quarterly operating expenses year-on-year change?
Over the past year, TELO quarterly total operating expenses has changed by +$4.93 M (+456.85%)